Opioids compared to placebo or other treatments for chronic low-back pain (Q24200220)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23983011 AND SRC:MED&resulttype=core&format=json

8 March 2020

meta-analysis

0 references

title

Opioids compared to placebo or other treatments for chronic low-back pain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23983011 AND SRC:MED&resulttype=core&format=json

8 March 2020

0 references

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23983011 AND SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Luis Enrique Chaparro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23983011 AND SRC:MED&resulttype=core&format=json

8 March 2020

Amol Deshpande

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23983011 AND SRC:MED&resulttype=core&format=json

8 March 2020

Angela Mailis-Gagnon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23983011 AND SRC:MED&resulttype=core&format=json

8 March 2020

Steven Atlas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23983011 AND SRC:MED&resulttype=core&format=json

8 March 2020

Dennis C Turk

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23983011 AND SRC:MED&resulttype=core&format=json

8 March 2020

publication date

27 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23983011 AND SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23983011 AND SRC:MED&resulttype=core&format=json

8 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23983011 AND SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

CD004959

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23983011 AND SRC:MED&resulttype=core&format=json

Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

The effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treating flare-up of chronic low-back pain: results from two randomized, double-blind, 6-week studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid-Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched, Randomized, Double-Blind, Placebo-Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions--the ACCPT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Transdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: a placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Oral controlled-release oxycodone for the treatment of chronic pain. Data from 4196 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

The pain quality response profile of oxymorphone extended release in the treatment of low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Opioid therapy for chronic noncancer back pain. A randomized prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Randomised trial of oral morphine for chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Efficacy and tolerability of paracetamol/tramadol (325 mg/37.5 mg) combination treatment compared with tramadol (50 mg) monotherapy in patients with subacute low back pain: a multicenter, randomized, double-blind, parallel-group, 10-day treatment st

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Opioid therapy for nonspecific low back pain and the outcome of chronic work loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Epidemiological features of chronic low-back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Opioid Therapy for Chronic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

The Saskatchewan health and back pain survey. The prevalence of low back pain and related disability in Saskatchewan adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Opioids for chronic low-back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

The failed back surgery syndrome: reasons, intraoperative findings, and long-term results: a report of 182 operative treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

A critical review of reviews on the treatment of chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Opioids for chronic noncancer pain: a new Canadian practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

A Comparison between Enriched and Nonenriched Enrollment Randomized Withdrawal Trials of Opioids for Chronic Noncancer Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Length of Disability and Cost of Workers' Compensation Low Back Pain Claims

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Attitudes toward opioid use for chronic pain: a Canadian physician survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Ethical issues in stopping randomized trials early because of apparent benefit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Rehabilitation after lumbar disc surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Surgery versus prolonged conservative treatment for sciatica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Predicting who develops chronic low back pain in primary care: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Treatment of chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Updated method guidelines for systematic reviews in the cochrane collaboration back review group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

The epidemiology of low back pain in the rest of the world. A review of surveys in low- and middle-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

The course of back pain in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

Clinicians' attitudes and beliefs about opioids survey (CAOS): instrument development and results of a national physician survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

Potent opioids for chronic musculoskeletal pain: flying blind?

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

Opioids in Italy: is marketing more powerful than the law?

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

What Factors Affect Physicians' Decisions to Prescribe Opioids for Chronic Noncancer Pain Patients?

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

Acute low-back pain. An objective analysis of conservative therapy

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

The relationship of disability to compensation status in railroad workers.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

An epidemiologic study of episodes of back pain care.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

Pharmacological management of persistent pain in older persons

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind multicentre trial*

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

A randomized, open-label, multicenter trial comparing once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe l

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

Onset of analgesic effect and plasma levels of controlled-release tramadol (Tramadol Contramid once-a-day) 200-mg tablets in patients with acute low back pain.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004959.PUB4

7 January 2021

10.1002/14651858.CD004959.PUB4

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23983011 AND SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017